Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 1404-1409, July 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billingham, R. E.
Right arrow Articles by Silvers, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billingham, R. E.
Right arrow Articles by Silvers, W. K.

The Use of Tolerance to Reduce the Complexity of Reactions to Antigen Mixtures1

R. E. Billingham and Willys K. Silvers

Department of Medical Genetics, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

A brief introductory account of the phenomenon of immunologic tolerance is presented as a basis for consideration of its possible application in experimental and clinical oncology.

Some of the various attempts which have been made to produce antibodies to tumor-specific determinants in heterologous hosts, previously treated to render them tolerant of the antigens of corresponding normal tissues, are critically reviewed. It is concluded that although the tolerance method of reducing the complexity of a host's reactions to antigen mixtures is theoretically sound and merits serious attention, it may sometimes fail to detect tumor-specific antigens. This may be due to the fact that the degree of specificity of tolerance is to some extent dependent upon the nature of the antigens concerned.

So far no study based upon the tolerance method has established unequivocally the existence of a tumor-specific antigen. The approach is certainly worth further investigation, but before more effort is expended upon analysis of the complex material afforded by human tumors, critical studies should be carried out upon murine tumors which are known to possess specific antigens, in order to establish the validity and practicability of the method.

1 The work of the authors in the field of immunologic tolerance has been supported by Grant AI 07001 of the USPHS.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.